Concord biotech to acquire 26% stake of Clean Max from CMEESPL

17 Jan 2025 Evaluate

Concord biotech has entered into a Share Purchase Agreement (SPA) with Clean Max Everglades (Clean Max) and Clean Max Enviro Energy Solutions (CMEESPL), whereby the Company will acquire 26% equity shares of Clean Max from CMEESPL. Investing in renewable energy aligns with the Company’s commitment to sustainability and it’s focused efforts to address environmental challenges. 

By transitioning to renewable energy sources, the company will reduce its carbon footprint, contributing to global efforts to combat climate change. Additionally, renewable energy offers long-term financial benefits, including reduction in energy costs. This strategic investment reinforces the Company’s commitment to environmental responsibility, ensuring compliance with evolving environmental regulations, and supporting sustainable growth while enhancing operational efficiency.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1115.00 -25.20 (-2.21%)
02-Feb-2026 15:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1313.00
Zydus Lifesciences 877.15
Lupin 2124.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×